Last updated: March 15, 2022
Sponsor: Hamilton Health Sciences Corporation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lactose Intolerance
Ulcerative Colitis
Gastrointestinal Diseases And Disorders
Treatment
N/AClinical Study ID
NCT03131414
REB#3000
Ages 4-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Each control that agrees to participate will undergo an initial screeningquestionnaire to confirm that they are healthy and have no gastrointestinal symptomsusing the ROME IV Questionnaire.
Exclusion
Exclusion Criteria:
- • major gastrointestinal surgery (Roux en y, bowel resection)
- any major comorbid chronic condition (e.g. decompensated liver disease ormalignancy, lung or cardiac disease, active HIV, diabetes mellitus requiringmedication,
- difficulties with communication or conditions affecting ability to provideinformed consent,
- unable to communicate in the language of the cohort study (English or French)
- those who do not wish to participate in this study
- diagnosis of schizophrenia
- diagnosis of eating disorder
Study Design
Total Participants: 8000
Study Start date:
October 01, 2017
Estimated Completion Date:
June 01, 2023
Study Description
Connect with a study center
Hamilton Health Sciences / McMaster University
Hamilton, Ontario L8N 3Z5
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.